Financial Summary (All financials)
In millions, except per share items | Jun-29-13 | Jun-30-12 | Jun-25-11 | Jun-26-10 | Jun-27-09 | Jun-26-08 | Jun-27-07 | Jun-28-06 |
Revenues | 3,539.8 | 3,173.2 | 2,755.0 | 2,268.2 | 2,005.6 | 1,729.9 | 1,368.4 | 1,366.8 |
Revenue growth | 11.6% | 15.2% | 21.5% | 13.1% | 15.9% | 26.4% | 0.1% | |
Cost of goods sold | 2,259.8 | 2,077.7 | 1,810.2 | 1,521.9 | 1,408.5 | 1,212.2 | 1,001.2 | 972.4 |
Gross profit | 1,280.0 | 1,095.5 | 944.8 | 746.2 | 597.1 | 517.7 | 367.2 | 394.4 |
Gross margin | 36.2% | 34.5% | 34.3% | 32.9% | 29.8% | 29.9% | 26.8% | 28.9% |
Selling, general and administrative | 473.8 | 411.8 | 364.4 | 298.3 | 255.9 | | | |
Sales and marketing | | | | | | 25.2 | 23.5 | 27.3 |
Research and development | 115.2 | 105.8 | 89.3 | 83.5 | 76.8 | 72.2 | 66.5 | 52.3 |
General and administrative | | | | | | 220.4 | 170.1 | 191.9 |
EBITA | 776.0 | 652.8 | 538.0 | 389.5 | 287.7 | 200.0 | 107.1 | 122.9 |
EBITA margin | 21.9% | 20.6% | 19.5% | 17.2% | 14.3% | 11.6% | 7.8% | 9.0% |
Amortization of intangibles | 94.0 | 74.8 | 46.8 | 25.1 | 23.6 | | | |
EBIT | 682.0 | 578.0 | 491.2 | 364.4 | 264.1 | 200.0 | 107.1 | 122.9 |
EBIT margin | 19.3% | 18.2% | 17.8% | 16.1% | 13.2% | 11.6% | 7.8% | 9.0% |
Pre-tax income | 607.7 | 512.0 | 450.6 | 308.6 | 206.3 | 177.9 | 87.1 | 105.9 |
Income taxes | 165.8 | 119.0 | 110.0 | 84.2 | 63.5 | 37.7 | 14.3 | 34.5 |
Tax rate | 27.3% | 23.2% | 24.4% | 27.3% | 30.8% | 21.2% | 16.4% | 32.6% |
Earnings from continuing ops | 441.9 | 384.4 | 342.0 | 225.1 | 140.1 | 140.2 | 72.8 | 71.4 |
Earnings from discontinued ops | | 8.6 | -1.4 | -0.6 | 2.7 | -4.4 | 1.0 | |
Net income | 441.9 | 393.0 | 340.6 | 224.4 | 142.8 | 135.8 | 73.8 | 71.4 |
Net margin | 12.5% | 12.4% | 12.4% | 9.9% | 7.1% | 7.8% | 5.4% | 5.2% |
|
Diluted EPS | $4.68 | $4.09 | $3.66 | $2.42 | $1.50 | $1.47 | $0.78 | $0.76 |
Shares outstanding (diluted) | 94.5 | 94.1 | 93.5 | 92.8 | 93.6 | 95.2 | 93.8 | 94.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|